Patents-Review.com
ClassID:

95824 ⎘

C07F9/02 - CPC Classification

Classification description:

Compounds containing elements of Groups 5 or 15 of the Periodic System Phosphorus compounds

Sub-classes:
Recent Application in this class:
#1
20250269038
2025-08-28

Olfactory Delivery Scaffolds Using Antisense Oligonucleotides and Methods for Making and Using Same

 #2
20220177478
2022-06-09

MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES

 #3
20210261612
2021-08-26

LLP2A-BISPHOSPHONATE CONJUGATES FOR OSTEOPOROSIS TREATMENT

 #4
20200369723
2020-11-26

LLP2A-BISPHOSPHONATE CONJUGATES FOR OSTEOPOROSIS TREATMENT

 #5
20200325165
2020-10-15

Ligand compound, organic chromium compound, catalyst system for olefin oligomerizatin, and method for oligomerizing olefin using same

 #6
20200136186
2020-04-30

Electrolyte solution for non-aqueous electrolyte battery, and non-aqueous electrolyte battery using the same

 #7
20200119400
2020-04-16

Electrolyte solution for non-aqueous electrolyte battery, and non-aqueous electrolyte battery using the same

 #8
20190346601
2019-11-14

Light-absorbing composition and optical filter

 #9
20190081358
2019-03-14

Liquid electrolyte, and method for manufacturing phosphate

 #10
20190077816
2019-03-14

Ligand compound, organic chromium compound, catalyst system for olefin oligomerization, and method for oligomerizing olefin using same

 #11
20180327528
2018-11-15

Ligand compound, catalyst system for olefin oligomerization, and method for oligomerizing olefins using the same

 #12
20180034103
2018-02-01

Electrolyte solution for non-aqueous electrolyte battery, and non-aqueous electrolyte battery using the same

 #13
20170312738
2017-11-02

Ligand compound, organic chromium compound, catalyst system for oligomerization of olefins, and method for oligomerizing olefins using the same

 #14
20170174722
2017-06-22

LLP2A-bisphosphonate conjugates for osteoporosis treatment

 #15
20170149087
2017-05-25

Liquid electrolyte, and method for manufacturing phosphate

 #16
20170029346
2017-02-02

Ligand compound, organic chromium compound, catalyst system for oligomerization of olefins, and method for oligomerization of olefins using the catalyst system

 #17
20160074461
2016-03-17

LLP2A-bisphosphonate conjugates for osteoporosis treatment

 #18
20150336990
2015-11-26

Production of lithium diphenylphosphide

 #19
20150183688
2015-07-02

Clay-compatible additive for construction chemicals

 #20
20140155640
2014-06-05

Surface Functionalised Nanoparticles

 #21
20140056855
2014-02-27

LLP2A-bisphosphonate conjugates for osteoporosis treatment

 #22
20130267482
2013-10-10

Alpha helix mimetics and methods relating thereto

 #23
20110311865
2011-12-22

IONIC LIQUID, ELECTROLYTE, LITHIUM SECONDARY BATTERY USING THE SAME, AND PROCESS FOR PRODUCING IONIC LIQUID

 #24
20110130349
2011-06-02

Compounds and Methods for Treating Toll-Like Receptor 2-Related Diseases and Conditions

 #25
20110092459
2011-04-21

Alpha helix mimetics and methods relating thereto

 #26
20100298121
2010-11-25

Production of lithium diphenylphosphide

 #27
20100129668
2010-05-27

Polyfluoroether-based phosphates

 #28
20100068522
2010-03-18

Surface functionalised nanoparticles

 #29
20090270289
2009-10-29

Phosphorus-molybdenum compound, method for producing same and lubricant additive and lubricant composition containing the compound

 #30
20090192062
2009-07-30

Phosphorus molybdenum compound and method for producing same

 #31
20090186855
2009-07-23

Compounds and methods for treating toll-like receptor 2-related diseases and conditions

 #32
20080113085
2008-05-15

Polyfluoroether-based phosphates

 #33
20070167409
2007-07-19

Compounds and methods for treating toll-like receptor 2-related diseases and conditions

 #34
20070117712
2007-05-24

CARBOXY-MODIFIED ALUMINUM-BASED CATALYST COMPOSITIONS

 #35
20060079431
2006-04-13

2-Hydroxy-3-alkoxypropyl sulfides, sulfones, and sulfoxides: new surface active agents

 #36
20050250867
2005-11-10

Polyurethane products including carboxy-modified aluminum-based catalysts

 #37
20050234209
2005-10-20

Carboxy-modified aluminum-based catalyst compositions

 #38
20050170508
2005-08-04

Gene delivery mediated by liposome-DNA complex with cleavable peg surface modification

 #39
20050113345
2005-05-26

Compounds and methods for treating Toll-like receptor 2-related diseases and conditions

 #40
13220788
2014-09-02

Process to prepare a phosphorous containing vegetable oil based lubricant additive